24 February 2026 -- California, US -- Illumina today announced the launch of TruPath Genome, setting a new standard for high-quality, comprehensive whole genome insights for genetic disease. TruPath Genome has been found to deliver unparalleled accuracy and resolution—even across so-called “dark regions” of the genome—providing researchers with a more complete picture of genomic alterations implicated in genetic disease.

24 February 2026 -- London, UK -- PMGroup Worldwide Ltd are pleased to announce the acquisition of Laboratory News magazine and website, together with Laboratory Talk website, from Synthesis Media.

23 February 2026 -- Illinois, US -- AbbVie today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus.

23 February 2026 -- Cambridge, UK -- Syndex Bio, a biotechnology company advancing next generation molecular diagnostics, today announced the introduction of its proprietary mcPCR (methyl copying PCR) platform at the Advances in Genome Biology and Technology (AGBT) conference in Orlando, Florida.

19 February 2026 -- Planegg, Germany -- leon-nanodrugs GmbH (LEON), a leading developer of advanced nanoencapsulation technology and equipment, and Harro Höfliger, a global expert in pharmaceutical engineering and GMP-compliant production, announced a strategic collaboration to expand worldwide access to LEON’s FR-JET® technology and portfolio of equipment.

12 February 2026 -- Munich and Planegg, Germany -- leon-nanodrugs GmbH today announced the successful closing of a financing round, with participation from both existing and new investors. The round was significantly oversubscribed, underscoring strong investor conviction in LEON’s proprietary technology, commercial readiness, and accelerating global demand for scalable nanoparticle manufacturing solutions.

11 February 2026 -- California, US and Pune, India -- OptraSCAN, a digital pathology company integrated with AI-enabled diagnostics, today announced the launch of BactoSiA, an AI-assisted tuberculosis (TB) treatment monitoring and follow-up solution designed to assist one of the most widely used tools in TB care: sputum smear microscopy.

11 February 2026 -- Teesside, UK -- FUJIFILM Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, celebrated the grand opening of its expanded site in Teesside, UK, today.

11 February 2026 -- London, UK -- Over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, will get together in London on 23rd April, 2026 for the 22nd Annual Anglonordic Life Science Conference

10 February 2026 -- London, UK -- Cenevo, which specializes in lab management systems, automation, orchestration, data management and AI technology for life sciences, is introducing two new AI agents as part of its focus on helping scientists operate faster, smarter and with less manual overhead, without sacrificing control or compliance.

10 February 2026 -- Eschborn, Germany -- AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, will highlight its growing product portfolio of reference materials, specialized laboratory chemicals & reagents, consumables and sample preparation solutions at Analytica 2026.

9 February 2026 -- Kolding, Denmark -- Unplanned downtime costs manufacturers billions of euros in lost revenue each year. Idle process lines cause product loss, extra cleaning, production delays, wasted water and potential damage to machinery. The AI-based condition monitoring solution ClariotTM from Alfa Laval provides 24/7 surveillance and actionable insights that enhance uptime and optimize resource efficiency.